Glutaredoxin 1

Glutaredoxin 1 Molekülinformation

Englischer Name	Glutaredoxin	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1	Target-Alias	Glutaredoxin-1，Thioltransferase，GRX，GLRX，Glutaredoxin，Thioltransferase-1，TTase-1，Glutaredoxin (Thioltransferase)，GRX1，Glutaredoxins
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Englischer Name	Glutaredoxin
Target-Alias	Glutaredoxin-1，Thioltransferase，GRX，GLRX，Glutaredoxin，Thioltransferase-1，TTase-1，Glutaredoxin (Thioltransferase)，GRX1，Glutaredoxins
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Glutaredoxin 1 Produktliste

Attribut
Protein (1)
Produktbibliothek
Online (1)
Spezies
Human (1)
Etikett
His Tag (1)
Marker
Unconjugated (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
GLX-H5149	Human	E. coli	Human Glutaredoxin 1 / GLRX1 Protein, His Tag				In den Warenkorb legen

Gesamtmenge1

Glutaredoxin 1 Molekülhintergrund

Glutaredoxin-1 (GRX1) is also known as Thioltransferase-1 (TTase-1), GLRX, GRX, GLRX1, which belongs to the glutaredoxin family. GRX1 / GLRX contains one glutaredoxin domain, which exists in either a reduced or an oxidized form. GRX1 / GLRX has a glutathione-disulfide oxidoreductase activity in the presence of NADPH and glutathione reductase and functions as electron carriers in the glutathione-dependent synthesis of deoxyribonucleotides by the enzymeribonucleotide reductase.

Glutaredoxin 1 Molekülalias

GLRX,GRX,TTase-1,GLRX1,GRX1

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Dimesna	NSC-716976; BNP-7787; LP-300	Phase 2 Clinical	Bionumerik	Adenocarcinoma of Lung; Anemia; Breast Diseases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Lung Neoplasms; Neoplasm Metastasis; Neutropenia	Details